WebFULL PRESCRIBING INFORMATION: CONTENTS* 1 INDICATIONS AND USAGE 1.1 Cutaneous Squamous Cell Carcinoma 1.2 . Basal Cell Carcinoma 1.3 . Non-Small Cell … Webfor PATIENT COUNSELING INFORMATION . Revised: 07/2012 . FULL PRESCRIBING INFORMATION: CONTENTS* 1 INDICATIONS AND USAGE . 2 DOSAGE AND ADMINISTRATION . 2.1 . Dosing Guidelines 2.2 . Hydration and Fluid Monitoring 2.3 . Dexamethasone Premedication 2.4 . Dose Modifications based on Toxicities 2.5 . …
(PDF) Unexpected toxicity of cetuximab combined with …
WebHead, Neck & Colorectal Cancer Treatment ERBITUX (cetuximab) See how ERBITUX may be able to help you Select the type of cancer you have. Colorectal cancer that has … WebSee 17 for PATIENT COUNSELING INFORMATION and Medication Guide. Revised: 01/2024 . FULL PRESCRIBING INFORMATION: CONTENTS* WARNING: INTERSTITIAL LUNG DISEASE and EMBRYO-FETAL TOXICITY . 1 INDICATIONS AND USAGE . 1.1 Metastatic Breast Cancer 1.2 Locally Advanced or Metastatic Gastric Cancer 2 DOSAGE … humana choice ppo in network hospitals
ERBITUX (cetuximab) injection - Food and Drug …
WebStore cetuximab vials under refrigeration at 36°F to 46°F (2°C to 8°C). Preparations of cetuximab in infusion containers are chemically and physically stable for up to. 12 hours at 36°F to 46°F (2°C to 8°C), or. 8 hours at controlled room temperature 68°F to 77°F (20°C to … WebHIGHLIGHTS OF PRESCRIBING INFORMATION . These highlights do not include all the information needed to use ... visible, white, amorphous, cetuximab particulates. Do not shake or dilute. 88 . 3 DOSAGE FORMS AND STRENGTHS 100 mg/50 mL, single-use vial . 200 mg/100 mL, single-use vial . 91 . WebFULL PRESCRIBING INFORMATION: CONTENTS * WARNING: CARDIOMYOPATHY, EMBRYO-FETAL TOXICITY, AND PULMONARY TOXICITY 1 INDICATIONS AND USAGE. 1.1 Early Breast Cancer (EBC) 1.2 Metastatic Breast Cancer (MBC) 2 DOSAGE AND ADMINISTRATION . 2.1 Patient Selection 2.2 . Important Dosage and Administration … holidays tours 24